OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hit the Road JAK! The Role of New Oral Treatment in Inflammatory Bowel Disease
Isabel Garrido, Susana Lopes, Guilherme Macedo
Inflammatory Bowel Diseases (2021) Vol. 27, Iss. 12, pp. 2010-2022
Closed Access | Times Cited: 7
Isabel Garrido, Susana Lopes, Guilherme Macedo
Inflammatory Bowel Diseases (2021) Vol. 27, Iss. 12, pp. 2010-2022
Closed Access | Times Cited: 7
Showing 7 citing articles:
JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases
Claudia Herrera‐deGuise, X Serra-Ruiz, Ernesto Lastiri, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 47
Claudia Herrera‐deGuise, X Serra-Ruiz, Ernesto Lastiri, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 47
Horizon scanning: new and future therapies in the management of inflammatory bowel disease
Aditi Kumar, Philip J Smith
eGastroenterology (2023) Vol. 1, Iss. 2, pp. e100012-e100012
Open Access | Times Cited: 13
Aditi Kumar, Philip J Smith
eGastroenterology (2023) Vol. 1, Iss. 2, pp. e100012-e100012
Open Access | Times Cited: 13
The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment
Jinwoo Kim, Su Young Kim
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11322-11322
Open Access | Times Cited: 20
Jinwoo Kim, Su Young Kim
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11322-11322
Open Access | Times Cited: 20
The role of upadacitinib in the treatment of ulcerative colitis
Ariel Jordan, Peter Higgins
Immunotherapy (2023) Vol. 15, Iss. 10, pp. 713-727
Closed Access | Times Cited: 6
Ariel Jordan, Peter Higgins
Immunotherapy (2023) Vol. 15, Iss. 10, pp. 713-727
Closed Access | Times Cited: 6
Use of upadacitinib in a child with refractory ulcerative colitis
А. С. Потапов, A. E. Pushkareva, A.V. Vinokurova, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 13, pp. 124-129
Open Access
А. С. Потапов, A. E. Pushkareva, A.V. Vinokurova, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 13, pp. 124-129
Open Access
The role of interleukin-6 and janus kinases in the pathogenesis, and treatment of SARS-CoV-2
Nightingale Syabbalo
Journal of Lung Pulmonary & Respiratory Research (2022) Vol. 9, Iss. 1, pp. 17-32
Open Access | Times Cited: 1
Nightingale Syabbalo
Journal of Lung Pulmonary & Respiratory Research (2022) Vol. 9, Iss. 1, pp. 17-32
Open Access | Times Cited: 1
Tofacitinib: una revisión de su uso en pacientes con colitis ulcerosa
José A. Romero-Lozanía, Korely C. Trujillo-de La Fuente, Rebeca Pérez‐Cabeza de Vaca, et al.
Revista mexicana de enfermedades inflamatorias inmunomediadas (2022) Vol. 1, Iss. 4
Open Access
José A. Romero-Lozanía, Korely C. Trujillo-de La Fuente, Rebeca Pérez‐Cabeza de Vaca, et al.
Revista mexicana de enfermedades inflamatorias inmunomediadas (2022) Vol. 1, Iss. 4
Open Access
